Home

Mesothelioma

• About Mesothelioma
• Mesothelioma Cause
• Mesothelioma Symptoms
• Mesothelioma Diagnosis
• Mesothelioma Stages

Mesothelioma Treatment

• Treatment Options
• Mesothelioma Surgery
• Mesothelioma Chemotherapy
• Mesothelioma Radiation
• New Approaches
• Palliative Care

Mesothelioma Specialists

• Choosing Your Doctor
• Your Health Care Team
• Cancer Centers

Clinical Trials

• Trial Basics
• Eligibility
• Current Trials

Managing Your Care

• Your Personal Records
• Your Medications
• Your Expenses

Veterans Resources

• Asbestos Disease
• Mesothelioma Detection
• Asbestos Exposure
• Veteran Service Officers

Clinical Trials at University of Chicago Comprehensive Cancer Center

Multicenter Randomized Comparative Phase III Trial of Onconase vs. Doxorubicin in Patients with Malignant Mesothelioma

Phase II Study of Capecitabine in Patients With Malignant Mesothelioma

Phase II Study of SU5416 in Patients With Unresectable Malignant Mesothelioma

Back to Comprehensive Cancer Centers

Contact Us

**For a FREE information packet including treatments, clinical trials, and specialists, please complete the form above or call a Mesothelioma Web coordinator at 1-877-367-6376.

News

• Mesothelioma News
• International News
• Pharmaceutical News
• Environmental News
• Medical Journal Articles

Resources

• Leading Cancer Links
• Financial Assistance, Compensation, and Legal Rights
• Disclaimer and Sponsorship Information

If you would like to receive a FREE information packet or have questions about mesothelioma, call us at:

Toll-Free 1-877-367-6376